Combined intravitreal triamcinolone injection and laser photocoagulation in eyes with persistent macular edema after branch retinal vein occlusion.

Graefe's Archive for Clinical and Experimental Ophthalmology = Albrecht Von Graefes Archiv Für Klinische Und Experimentelle Ophthalmologie
Juliane RieseHeinrich Gerding

Abstract

To determine the efficacy of combined intravitreal triamcinolone (TA) injection and laser photocoagulation in persistent macular edema after branch retinal vein occlusion (BRVO). Follow-up analysis of a case series of 24 patients with macular edema after BRVO (15 of 24 non-ischaemic, 9 of 24 ischaemic). Patients received an intravitreal injection of 4 mg TA followed by laser photocoagulation within the previously edematous area, applied in one or two sessions. Standardized clinical examinations included best corrected visual acuity testing, anterior and posterior segment biomicroscopy, intraocular pressure, and optical coherence tomography (OCT). Fluorescein angiography was performed before treatment and 3 and 6 months later. Median visual acuity improved significantly from 0.58 logMAR (95%-confidence interval (KI): 0.54-0.75, decimal 0.27) at baseline to 0.41 logMAR (KI: 0.37-0.64, decimal 0.39) at 1 month (p = 0.001), 0.33 logMAR (KI: 0.32-0.62, decimal 0.47) at 3 months (p = 0.002), and 0.41 logMAR (KI: 0.33-0.67, decimal 0.39) at 6 months (p = 0.016). A gain of one or more logarithmic lines was evaluated in 16/24 eyes (67 %) and a gain of 3 lines or more in 8/24 eyes (33 %) at 6 months. Three eyes had lost more than 1 line ...Continue Reading

References

Mar 1, 1984·The British Journal of Ophthalmology·J S Shilling, C A Jones
Sep 15, 1984·American Journal of Ophthalmology·A Patz
Aug 1, 1980·Australian Journal of Ophthalmology·D V GreerR L Cooper
Jan 15, 2000·Archives of Ophthalmology·W M Tang, D P Han
Feb 2, 2000·Graefe's Archive for Clinical and Experimental Ophthalmology = Albrecht Von Graefes Archiv Für Klinische Und Experimentelle Ophthalmologie·M Battaglia ParodiG Ravalico
Jan 5, 2002·Graefe's Archive for Clinical and Experimental Ophthalmology = Albrecht Von Graefes Archiv Für Klinische Und Experimentelle Ophthalmologie·S SaikaY Ohnishi
Apr 30, 2005·American Journal of Ophthalmology·Tom H Williamson, Annie O'Donnell
Oct 18, 2005·American Journal of Ophthalmology·Teresio AvitabileAlfredo Reibaldi
Jun 10, 2006·Ophthalmic Research·Jost B Jonas
Jan 24, 2008·The British Journal of Ophthalmology·T C KreutzerS Priglinger
Jan 24, 2008·The British Journal of Ophthalmology·K KriechbaumU Schmidt-Erfurth
Mar 26, 2008·Molecular Therapy : the Journal of the American Society of Gene Therapy·Peter A CampochiaroJoseph R Arron

❮ Previous
Next ❯

Citations

Sep 21, 2013·Ophthalmic Surgery, Lasers & Imaging Retina·Eric W SchneiderSeenu M Hariprasad
Sep 6, 2014·Expert Opinion on Pharmacotherapy·Valentina SaraoPaolo Lanzetta
Nov 1, 2013·Seminars in Ophthalmology·Irini P ChatziralliMarilita M Moschos
Jul 13, 2012·Seminars in Ophthalmology·John D PitcherJean-Pierre Hubschman
Jun 2, 2012·Ophthalmologica. Journal international d'ophtalmologie. International journal of ophthalmology. Zeitschrift für Augenheilkunde·Mitsuru ArimaTatsuro Ishibashi
Jan 1, 2009·Journal of Ophthalmic & Vision Research·Siamak Moradian, Ramin Nourinia
Nov 1, 2012·Asia-Pacific Journal of Ophthalmology·Jost B Jonas, Dennis S C Lam
Dec 9, 2010·European Journal of Ophthalmology·Angel Salinas-AlamánAlfredo García-Layana
Mar 14, 2021·Progress in Retinal and Eye Research·Sohan Singh Hayreh

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.